# Turn Therapeutics Inc. (TTRX)

> Source: Nexqual · https://nexqual.com/TTRX · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Turn Therapeutics Inc. (TTRX), nexqual.com/TTRX" · informational, not investment advice.

**Price:** USD 11.59 (+4.32% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 11.11 · day 11.15–11.89 · 52w 2.57–16.45 · market cap $352M · NGM

## Key facts
- Analysts: Buy (mean 2.00 on a 1–5 scale) (2 analysts), mean target USD 25 (range 24–26).
- Total return with dividends: 1Y +105.5% vs S&P 500 +18.1%; 5Y +55.6% vs S&P 500 +85.1%.
- Next earnings: 2026-11-12, EPS estimate USD -0.09, revenue estimate $0K.

## Analysts
Consensus Buy (mean 2.00 on a 1–5 scale), 2 analysts; mean target USD 25 (low 24, high 26).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-24 | LUCID CAPITAL MARKETS | Initiated | Buy | $24 |
| 2026-09-14 | WBB Securities | Downgrade | Hold → Sell | $10 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2025-10-06) |
|---|---|---|
| Total return | +105.5% | +55.6% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +106.0% | +53.9% |
| Volatility (annualized) | 99.8% | 103.4% |
| Max drawdown | -52.0% (Oct 2025→Nov 2025) | -63.2% (Oct 2025→Dec 2025) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/TTRX · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt